Pradaxa: Profits Put Before Safety
10/04/13
Pradaxa (dabigatran), was approved in October 2011 and is used as an alternative to the blood thinning drug warfarin. It treats a type of irregular heartbeat, called non-valvular atrial fibrillation (AF) and helps to prevent strokes. Pradaxa outperformed warfarin in clinical trials in reducing the risk of stroke and it also appeared to be safer, [...]


